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Summary
Background Several pieces of evidence indicate that a complex relationship exists
between constitutional telomere length (TL) and the risk of cutaneous melanoma.
Although the general perception is that longer telomeres increase melanoma risk,
some studies do not support this association. We hypothesize that discordant data
are due to the characteristics of the studied populations.
Objectives To evaluate the association of TL with familial and sporadic melanoma.
Materials and methods TL was measured by multiplex quantitative polymerase chain
reaction in leukocytes from 310 patients with melanoma according to familial/
sporadic and single/multiple cancers and 216 age-matched controls.
Results Patients with sporadic melanoma were found to have shorter telomeres
compared with those with familial melanoma. In addition, shorter telomeres,
while tending to reduce the risk of familial melanoma regardless of single or
multiple tumours, nearly trebled the risk of single sporadic melanoma.
Conclusions This is the first time that TL has been correlated to opposite effects on
melanoma risk according to the presence or absence of familial predisposition.
Individual susceptibility to melanoma should be taken into account when assess-
ing the role of TL as a risk factor.
What’s already known about this topic?
• The role of telomere biology in tumorigenesis is complex and influenced by multi-
ple mechanisms, even acting in opposite directions.
What does this study add?
• Constitutive telomere length is significantly different between familial and sporadic
melanoma.
• Short telomeres increase the risk of single sporadic melanoma, but decrease that of
familial melanoma.
What is the translational message?
• Individual susceptibility to cancer should be taken into account when assessing the
role of telomere length as a cancer risk factor.
Telomeres are dynamic nucleoprotein complexes located at the
ends of chromosomes, which maintain genomic stability by
protecting the chromosomes against degradation, end-to-end
fusion and atypical recombination.1 Telomeres consist of
nucleotide repeats that shorten with each cell division; when
they reach a critical short length, cells undergo senescence or
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apoptosis, providing a barrier against cancer development.2,3
However, telomere erosion may lead to genomic instability, a
key event in carcinogenesis.4 Several epidemiological studies
have analysed the potential role of telomere length (TL) on
the risk of cancer, and their results indicate that the relation-
ship between TL and tumorigenesis is complex and probably
tumour-type specific.5 Regarding cutaneous melanoma, much
evidence supports the important role of telomere biology in
the onset and progression of disease.6–13
Although most studies indicate a positive relationship
between TL and melanoma risk (reviewed by Caini et al.14),
others do not,8,15 or else they show an association in particular
subgroups. For instance, Han et al.10 reported a weak positive
association between TL and melanoma risk after examining
female patients of whom 365% had a family history of skin
cancer. Anic et al.6 also reported a significant association
between TL and melanoma risk among women, but not in
men, whereas Nan et al.13 described such a relationship in a
cohort of 120 male subjects. Bodelon et al.,8 analysing a pool of
sporadic and familial cases of melanoma, found no association
between TL and melanoma risk, although Burke et al.9 described
a significant positive association between TL and melanoma risk
in familial melanoma cases without mutations in the CDKN2A
gene, but not in CDKN2A mutation carriers. The positive rela-
tionship between TL and number of melanocytic naevi, a well-
known risk factor for melanoma, is also still under debate.7–9,16
Melanoma is a complex disease with multifaceted aetiology,
involving phenotypic (e.g. light phototype, number of melano-
cytic naevi), genetic and environmental factors, and their com-
bination and prevalence generates different pathways for the
development of melanoma. In the presence of mutations in
high penetrance melanoma predisposition genes (e.g. CDKN2A),
familial clustering of cases is observed. Environmental factors,
such as sun exposure and sunburn, are the major risk factors
for sporadic melanoma cases.17,18 Both the number of naevi
and presence of dysplastic naevi are predominant risk factors in
multiple primary melanoma.19 Although melanomas occurring
in a familial setting do not seem to have significantly different
prognostic factors and survival rates when compared with spo-
radic melanoma,20 several studies highlight some differences
among groups, such as earlier age at onset, absence of clinically
detected sun damage, lower Breslow thickness and higher rate
of multiple primary melanomas in familial cases.21–23
We hypothesized that the discordant results in the literature
between TL and melanoma risk are due to the characteristics of
the studied populations, with special regard to the presence or
absence of familial predisposition. Thus, the aims of this study
were to investigate whether TL was differentially correlated with
familial or sporadic and multiple or single melanoma.
Materials and methods
Study population
This case–control study comprised 310 patients with mela-
noma referred to the Melanoma and Sarcoma Unit of the
Veneto Institute of Oncology in Padova, Italy, between 2007
and 2013. All cases of melanoma diagnosis were confirmed
by pathology reports; naevus count was calculated as patients
with < 10, 10–50, or > 50 melanocytic naevi, according to
physical examination by a trained dermatologist. Patients with
a family history of melanoma (defined by personal interviews
as having at least one other confirmed case of melanoma
among first- or second-degree relatives) were grouped as
familial melanomas (FM), and patients with no such family
history as sporadic melanomas (SpM). All patients with more
than one subsequent melanoma were included in the multiple
primary melanoma group (MPM) (median follow-up:
35 years, range 02–211 years). Patients were included in
the single primary melanoma group (SiM) if they had not had
a second melanoma within at least a 3-year period from the
first diagnosis (median follow-up: 79 years, range 30–
343 years). Details of sex, age at blood sampling and naevus
count are listed in the Supporting Information (see Table S1).
No patient showed spread of disease or was under chemother-
apy at the time of blood sampling. All melanoma cases were
screened for germline mutations in the CDKN2A gene, as previ-
ously described,24 and no mutations were found. Controls
were 216 healthy individuals without personal or familial
antecedents of cancer, collected between 2011 and 2012 at
the Blood Collection Centre, Hospital Transfusion Centre of
Padova. They were frequency-matched by age and sex to cases
(n = 94, 435% men; n = 122, 565% women;
538  SD = 139 years, mean age at blood sampling). All
patients and controls were of Caucasian origin. Written
informed consent was obtained from all participants, as
approved by the local institutional ethics committee.
Telomere length measurement
Relative TL was determined by monochrome quantitative mul-
tiplex polymerase chain reaction (PCR) assay,25 with minor
modifications. All DNA samples were extracted from leuko-
cytes with the QIAmp DNA kit (Qiagen; Milan, Italy) and
their quality and concentration were assessed by both ultravio-
let (UV) spectroscopy and agarose gel electrophoresis. The
primer pair employed for telomere amplification were: TELG
50-ACACTAAGGTTTGGGTTTGGGTTTGGGTTTGGGTTAGTGT-30,
and TELC 50-TGTTAGGTATCCCTATCCCTATCCCTATCCCTAT
CCCTAACA-30. The primer pair for amplification of single-
copy gene albumin were: ALBU 50-CGGCGGCGGGCGGCGC
GGGCTGGGCGGAAATGCTGCACAGAATCCTTG-30 and ALBD
50-GCCCGGCCCGCCGCGCCCGTCCCGCCGGAAAAGCATGGTCG
CCTGTT-30. Single-copy gene albumin was amplified simulta-
neously with the telomere template in the same well and used
as a reference, to adjust for differing amounts of DNA in dif-
ferent samples. Each PCR reaction was performed in a final
volume of 25 lL, containing 5 lL sample (1 ng DNA lL1)
and 20 lL reaction mix containing 075 9 SYBR Green I
(Invitrogen, Milan, Italy), 10 mmol L1 Tris–HCl pH 83,
50 mmol L1 KCl, 3 mmol L1 MgCl2, 02 mmol L1 each
dNTP (Applied Biosystems; Foster City, CA, U.S.A.),
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1 mmol L1 DTT, 0625 U AmpliTaq Gold DNA polymerase,
1% DMSO (Sigma-Aldrich; Milan, Italy) and 900 nmol L1 of
each primer. PCR reactions were performed on a Light-
Cycler480 real-time PCR detection system (Roche Applied
Science; Milan, Italy). The thermal cycling profile was 15 min
at 95 °C, two cycles of 15 s at 94 °C and 15 s at 49 °C, fol-
lowed by 40 cycles of 15 s at 94 °C, 10 s at 62 °C, 15 s at
74 °C, 10 s at 84 °C and 15 s at 88 °C, with signal acquisi-
tion at the end of the 74 °C and 88 °C steps. A standard curve
was generated at each PCR run, consisting of DNA from the
RAJI cell line, serially diluted from 100 to 041 ng lL1.26 All
DNA samples and reference samples were run in triplicate.
LightCycler raw text files were converted to grid format with
LC480Conversion free software developed by the Heart Failure
Research Centre, Amsterdam, the Netherlands (http://
www.hartfaalcentrum.nl/index.php?main=-
files&fileName=LC480Conversion.zip&description=LC480%
20Conversion&sub=LC480Conversion). The converted data
were analysed with LinRegPCR free software developed by
Ruitjer et al.27 All DNA samples, from both cases and con-
trols, were blind and consecutively run in triplicate together
with reference samples. The intra- and inter-assay repro-
ducibility of both telomere and albumin PCR results was
evaluated with dilutions of the reference curve and three
DNA samples from patients. The SD of cycle threshold (Ct)
values was ≤ 019 (% coefficient of variation ≤ 094) in six
replicates of samples amplified in the same PCR run, and
≤ 028 (% coefficient of variation ≤ 131) among mean val-
ues of triplicates in different PCR runs. Mean Ct values
were used to calculate the relative TL, with the telomere/sin-
gle-copy gene ratio according to the formula: DCtsam-
ple = CttelomereCtalbumin, DDCt = DCtsampleDCtreference curve
(where DCtreference curve = Cttelomere_RAJICtalbumin RAJI) and then
T/S = 2DDCt.26
Statistical analysis
Linear regression was used to model the relationship between
TL and covariates, i.e. diagnosis of melanoma, family history,
presence of multiple lesions and number of naevi, with adjust-
ments for age as a continuous variable and its first-order inter-
action with each covariate considered. The association
between TL and the risk of each melanoma case-type status
(i.e. melanoma, familial melanoma, sporadic melanoma, etc.)
was determined with a set of logistic regressions, adjusted for
age and sex. TL was used as a categorical variable to account
for a potential nonlinear relationship between TL and mela-
noma risk, and classified according to the quartiles of telomere
distribution of controls; the fourth quartile, the longest TL,
was used as the reference. All tests were two-sided and a
P < 005 was considered statistically significant. Statistical
analyses were performed with SAS, version 913 (SAS Insti-
tute; Cary, NC, U.S.A.).
Analysis of false-positive report probability (FPRP) was con-
ducted to assess the probability of finding a false positive in a
statistically significant test.28 The FPRP value for a given
association was calculated with a prior probability of 02 and
the statistical power to detect an odds ratio (OR) of 05. An
association with an FPRP value below 02 was declared note-
worthy.
Results
Telomere length in sporadic and familial melanoma
We analysed TL from 109 familial (FM) and 201 sporadic
(SpM) cases of melanoma, and found that FM samples had
longer telomeres than those of SpM cases (Fig. 1a). The age-
adjusted linear regression of TL was calculated (Fig. 1b), and
significant differences emerged between the groups [mean
TL_FM vs. mean TL_SpM: 1075, 95% confidence interval (CI):
1024–1125 vs. 0958; 95% CI: 0921–0995; P < 0001].
Notably, the rate of telomere shortening by age in FM was
higher than in SpM (slope TL_FM vs. slope TL_SpM: 0011,
95% CI: 0015 to 0008 vs. 0005, 95% CI: 0007 to
0002; P = 0005).
Interestingly, when the TL of both groups was compared
with that obtained from a control cohort of 216 healthy indi-
viduals (mean TL_controls: 1013; 95% CI: 0976–1049),
frequency-matched for age and sex, FM and SpM were
observed to have TL longer and shorter than controls, respec-
tively (Fig. 2). No differences emerged when the TL of overall
cases was compared with controls after adjusting for age and
sex (P = 0602; Fig. S1; see Supporting Information).
Hence, familial and sporadic melanomas are characterized
by different TLs, and a significant opposite interaction
emerged between melanoma groups with respect to controls,
suggesting an opposite effect on melanoma risk.
Telomere length in patients according to number of naevi
and presence of multiple melanoma
We analysed the association between TL and naevi, as well as
the occurrence of multiple melanomas. Matching previous
reports,7 age-adjusted TL turned out to be positively associ-
ated with increased naevus count (P = 0011) (Fig. S2; see
Supporting Information), whereas TL did not significantly dif-
fer between patients with multiple (MPM) or single mela-
noma (SiM) (Fig. S3; see Supporting Information). However,
multivariate analysis including all available covariates showed
that TL was significantly correlated with family history (SpM
vs. FM P = 0009) but not with naevus count or presence of
MPM (Table 1). Hence, both single and multiple melanoma
cases were analysed separately according to familial character-
istics. In this subgroup analysis, we found that the age-
adjusted TL in the SiM group significantly differed between
sporadic and familial cases (SiSpM vs. SiFM; 093 vs. 108;
P < 0001), whereas in the MPM group no difference
emerged between sporadic and familial cases (MSpPM vs.
MFPM; 100 vs. 106; P = 0312) (Table 2).
The opposite association between TL and familial or spo-
radic melanoma was emphasized by the results of FPRP
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analysis. The association with TL was in fact found in both
sporadic and familial melanoma and in single sporadic and
familial melanoma, supporting the findings of a reduced risk
of being sporadic and single sporadic melanoma for every
one-unit increase in TL, after adjusting for age (Table S2; see
Supporting Information).
(a)
(b)
Fig 1. Comparison of telomere length (TL)
between cases of familial and sporadic
melanoma. (a) Box plots showing distribution
of raw values of TL in cases of familial (109)
and sporadic (201) melanoma. Upper and
lower limits of the boxes show 75th and 25th
percentiles, respectively; horizontal bar across
the box indicates the median. (b) TL
distribution as a function of age for cases of
familial (white circles) and sporadic (black
circles) melanoma. Regression lines and
respective equations are shown.
Fig 2. Correlation between telomere length
(TL) and age in sporadic and familial
melanoma cases and controls. Multiple linear
regression model for each group and pairwise
mean TL differences with 95% confidence
intervals are shown.
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Telomere length and melanoma risk
We then estimated the effect of TL on melanoma risk for the
familial and sporadic patient group, using a model adjusted
for age and sex. Cases were categorized into quartiles based
on the TL distribution of controls. As Table 3 shows, shorter
TLs were observed to be associated with a decreased risk in
familial cases (FM: OR = 046; 95% CI: 023–095) and an
increased risk in sporadic cases (SpM: OR = 174; 95% CI:
100–304) compared with longer TL, whereas TL did not
modify the risk of melanoma when all cases were taken into
account.
When the analysis was performed in subgroups of mela-
noma cases also taking into account the presence or absence
of MPM, the increase in melanoma risk in sporadic melanoma
cases with shorter TL was more evident in patients with single
melanoma (SiSpM: OR = 261; 95% CI: 134–510,
P = 0008) but the risk was not related to TL in cases of mul-
tiple sporadic melanomas (MSpPM: OR = 104; 95% CI:
050–217, P = 0909). In the familial subgroups, the associa-
tion between decreased risk and shorter telomeres did not vary
according to the presence or absence of multiple melanomas,
although it did not reach statistical significance, probably
because of the small sample size (SiFM: OR = 048, 95% CI:
021–107, P = 0168; MFPM: OR = 042, 95% CI: 014–
130, P = 0078).
Discussion
To our knowledge, this is the first study examining the rela-
tionship between TL and melanoma risk according to familial
or sporadic status, also taking into account the occurrence of
multiple or single tumours. We observed that constitutive TL
was significantly longer in familial than in sporadic mela-
noma, and that different kinetics of TL shortening with age
emerged between the groups, indicating the different role
played by TL in the pathogenesis of familial or sporadic mela-
noma. We also found that TL, which was longer and shorter
Table 1 Multiple linear regression model to test effects of family
history, naevus count and presence of multiple melanoma on age-
adjusted telomere length (TL)
Characteristics Cases, n (%) TL, meana (95% CI)
Melanoma group
Sporadic (SpM) 183 (665) 096 (092–100)
Familial (FM) 92 (335) 106 (099–112)
P-value 0009
Naevus count
< 10 47 (171) 097 (088–106)
10–50 123 (447) 099 (094–105)
> 50 105 (382) 106 (105–112)
P-value 0185
Number of melanomas
1 = Single (SiM) 161 (585) 101 (096–106)
≥ 2 = Multiple (MPM) 114 (415) 101 (094–107)
P-value 0946
aEstimated mean TL values with 95% confidence intervals (CI).
P-values of differences between groups are reported.
Table 2 Subgroup analysis to test effects of family history and
presence of multiple melanoma on telomere length (TL) by age-
adjusted multiple linear regression model
Subgroup patients Cases, n (%) TL Meana (95% CI)
Single melanoma
Sporadic (SiSpM) 121 (390) 093 (088–098)
Familial (SiFM) 69 (223) 108 (101–114)
P-value < 0001
Multiple melanoma
Sporadic (MSpPM) 80 (258) 100 (094–107)
Familial (MFPM) 40 (129) 106 (097–115)
P-value 0312
aEstimated mean TL values with 95% confidence intervals. P-
values of differences between groups are reported.
Table 3 Association between telomere length and melanoma risk in
overall and stratified patients
Telomere length
Cases,
n (%) OR (95% CI) P-values
All melanoma
First quartile < 0831 99 (32) 114 (069–188) 0677
Second quartile
0831–0967
58 (19) 067 (040–111)
Third quartile
0968–1134
66 (21) 076 (046–124)
Fourth quartile ≥ 1135 87 (28) 1
Familial melanoma (FM)
First quartile < 0831 23 (21) 046 (023–095) 0046
Second quartile
0831–0967
22 (20) 047 (024–092)
Third quartile
0968–1134
21 (19) 047 (025–090)
Fourth quartile ≥ 1135 43 (40) 1
Sporadic melanoma (SpM)
First quartile < 0831 76 (38) 174 (100–304) 0049
Second quartile
0831–0967
36 (18) 083 (046–149)
Third quartile
0968–1134
45 (22) 102 (058–179)
Fourth quartile ≥ 1135 44 (22) 1
Single sporadic melanoma (SiSpM)
First quartile < 0831 51 (42) 261 (134–510) 0008
Second quartile
0831–0967
21 (17) 104 (051–215)
Third quartile
0968–1134
28 (23) 137 (069–271)
Fourth quartile ≥ 1135 21 (17) 1
OR, odds ratio estimated by logistic regression analysis adjusted
for age and sex; CI, confidence interval. P-values of the trend are
reported.
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in FM and SpM than controls, respectively, plays the opposite
role in melanoma risk, according to the presence or absence
of familial predisposition. Short telomeres reduced the risk of
familial melanoma by more than half, regardless of single or
multiple tumours, but they nearly trebled the risk in sporadic
cases with only one melanoma. This effect was not detected in
sporadic cases with multiple lesions, suggesting that other risk
factors are involved in these melanoma-prone individuals.
Thus, on one hand, our data confirm previous results showing
a direct association between TL and melanoma risk in mela-
noma-prone families;9 on the other, they add the new finding
of an inverse association between TL and melanoma risk in
single sporadic cases.
Approximately 10% of cutaneous melanomas occur in a
familial setting, and a different aetiology arises between famil-
ial and sporadic melanoma, as certain inherited traits play a
critical role in the onset of the former and environmental fac-
tors in the latter. In this regard, the role of exposure to sun-
light, an important environmental risk factor for melanoma, is
under discussion in families with high disease susceptibil-
ity,17,18 in which genetic determinants are more predictive of
cancer risk. It is interesting in this context to examine the
hypothesis of Whiteman et al.,29 that cutaneous melanoma
develops along two diverging pathways: one naevus-depen-
dent, in which melanocytes of naevus-prone individuals are
induced to proliferate by host factors contributing to
melanomagenesis with little sun exposure; and the other UV
light-dependent, in which melanocytes become malignant
after intense sun exposure. According to its clinical and
histopathological characteristics, familial melanoma has been
associated with the former pathway,21 matching previous data
showing that sun exposure is not associated with melanoma
risk in melanoma-prone families.17,18
Iles et al.30 recently demonstrated that germline genetic
determinants underlying long telomeres increase the mela-
noma risk in a large cohort of patients preferentially selected
for family history or multiple primary tumours. Long telom-
eres, characterizing familial cases, may confer a high cellular
replicative potential, which in turn favours additional genetic
mutations and the development of melanoma. Conversely, in
the absence of constitutive predisposing factors, as in the case
of single sporadic melanoma, telomere shortening may con-
tribute to melanoma development by inducing genetic insta-
bility, as reported for other tumour histotypes.31 This
opposite effect of TL on melanoma risk according to familial
or sporadic status may reproduce the dual roles of telomere
biology in tumorigenesis32 and support the divergent path-
ways hypothesis in melanomagenesis.29 Genetic determinants
that favour long telomeres and cluster in a familial setting do
increase replicative potential,30 favouring the naevus-depen-
dent pathway of melanoma, whereas environmental factors,
such as exposure to the sun, induce telomere shortening33
and genetic instability, favouring a UV light pathway in spo-
radic melanoma.
Following the model very recently advanced by Rode
et al.,34 the association between short telomeres and sporadic
cancer that we observed may also be considered as an observa-
tional analysis due to a confounding factor, such as UV expo-
sure, which can lead independently to both telomere
shortening and increased melanoma risk. Conversely, the asso-
ciation between long telomeres and familial melanoma is
more probably due to genetic disposition, and the effect of
melanoma risk derives from the sum of alleles leading to long
telomeres, which may increase cancer cell replication.
Unfortunately, in the present study we could not evaluate
interactions between telomere and environmental risk factors,
such as exposure to sunlight, because some patient informa-
tion was missing. Larger studies on familial and sporadic mel-
anoma will be required to confirm the association among
genetic and environmental determinants, TL and familial sta-
tus. Another limitation of our study is that the family history
was ascertained primarily through personal interviews, and
these findings should therefore be validated in other familial
and sporadic melanoma sample sets. Nonetheless, our consid-
erations should be contextualized according to tumour histo-
type, in that short telomeres seem to be associated with an
increased cancer risk in both familial and sporadic cases in
ovarian cancer35 and in hereditary but not sporadic cases in
breast cancer.36
In conclusion, the role of telomeres in the genesis of mela-
noma is complex, and both short and long telomeres may
increase the individual risk of melanoma, depending on other
predisposing/risk factors. Emerging and future studies on the
genetics of telomere biology will help to better define the
complex relationship between TL and the risk of cutaneous
melanoma.
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Supporting Information
Additional Supporting Information may be found in the online
version of this article at the publisher’s website:
Table S1. Mean age at blood sampling and mean telomere
length (TL) in patients with melanoma stratified by character-
istics.
Table S2. False-positive report probability values for the
logistic regression analysis of association of telomere length
with the probability of sporadic or single sporadic melanoma,
adjusted for age.
Fig S1. Correlation between telomere length (TL) and age
in melanoma cases and controls. TL distribution as a function
of age for melanoma cases (grey circles) and controls (white
circles). Regression lines and respective equations are shown.
Estimated mean TL values at mean age, with 95% confidence
intervals (CI) and pairwise differences between cases and con-
trols are reported under the graphic.
Fig S2. Correlation between telomere length (TL) and age
in cases of melanoma stratified according to number of naevi.
TL distribution as a function of age for melanomas with high
(> 50 total naevi; black circles), medium (10–50 total naevi;
grey circles) and low (< 10 total naevi; white circles) naevus
counts. Regression lines and respective equations are repre-
sented for each group. Estimated mean TL values at mean age,
with 95% confidence intervals (CI) and pairwise differences
between groups are reported under the graphic.
Fig S3. Correlation between telomere length (TL) and age
in multiple and single melanoma cases. TL distribution as a
function of age for multiple (white circles) and single (grey
circles) cases of melanoma. Regression lines and respective
equations are represented for each group. Estimated mean TL
values at mean age, with 95% confidence intervals (CI) and
pairwise differences between multiple and single melanomas
are reported under the graphic.
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